Merck KGaA

Company Snapshot

Founded: 1668
Entity Type: Public
Employees: 62,461
Region: Asia-Pacific
Revenue: $23,866.8 Millions
Revenue Year: 2025
Segment: Life Science
Headquarter: Darmstadt, Germany
Key Geographics: Europe, North America, Latin America, Middle East & Africa, Asia-Pacific
Corporate Address: Frankfurter Strasse 250 Darmstadt, 64293, Germany Tel. +49-615-1720 www.merckgroup.com

Company Overview

Merck KGaA, a global science and technology company, operates across three major business sectors: life science, healthcare, and electronics. Its life science sector, branded as MilliporeSigma in North America and Merck in other markets, delivers a portfolio of over 300,000 catalog products to pharmaceutical, biotechnology, academic, and industrial laboratory customers. The life science sector includes three segments: science and lab solutions, process solutions, and life science services. The segments provide foundational laboratory reagents, biomanufacturing materials, and contract testing and development services.

Merck KGaA’s life science offerings include cell-based assays, hepatocyte and enzymatic models, cytotoxicity detection kits, transporter assay reagents, high-content imaging dyes, and consumables that support drug safety, mechanistic toxicology, and cell-based screening workflows. The products enable researchers to assess cytotoxicity, hepatotoxicity, transporter-mediated effects, and metabolism-related risks during the early stages of drug discovery and development.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Merck KGaA In Reports

In Vitro Toxicity Testing: Technologies and Global Markets

BCC Research detailed report on in vitro toxicity testing market includes global revenue ($ Million) for base year data 2024 and estimated data for the forecast period 2025 through 2030.

Global Markets for Protein Labeling

BCC Research detailed report on protein labeling market analysis uses 2024 as the base year, includes estimates for 2025, and projects trends through 2030.

Global DNA Read, Write, and Edit Market

BCC Research detailed report on DNA Read, Write and Edit Market includes global revenue ($ Million) for the base year 2024 and estimated data for the forecast period 2025 through 2030.

Company's Business Segments

  • Life Science : Science & Lab Solutions, Process Solutions and Life Science Services
  • Healthcare : Oncology, Erbitux, Bavencio, Neurology & Immunology, Rebif, Mavenclad, Fertility, Gonal-f, Cardiovascular, Metabolism & Endocrinology
  • Electronics : Semiconductor Solutions, Display Solutions and Surface Solutions

Applications/End User Industries

  • Neurological Disorders
  • Immunological Diseases
  • Multiple Sclerosis
  • Reproductive Health And Fertility
  • Cardiovascular Diseases
  • Metabolic Disorders
  • Endocrine Disorders
  • Scientific Research
  • Laboratory Work
  • Reagents
  • Semiconductor Manufacturing
  • Liquid Crystals
  • Automotive Electronics
  • Electronic Applications
  • Consumer Electronics
  • Filtration Systems
  • Contract Research
  • Process Development
  • Biopharmaceutical Manufacturing
  • Therapies For Cancer Treatment
  • Oncology
  • Neurology & Immunology
  • Fertility
  • Endocrinology
  • Pharma Biotech
  • Diagnostics
  • Government & Academic Research
  • Industrial
  • Semiconductor Solutions
  • Display Solutions
  • Surface Solutions
  • Advancing Digital Living with Electronics
  • Healthcare Pipeline
  • Clinical Trials
  • Global R&D Hubs
  • Artificial Intelligence - AI Research
  • Global Health Institute
AI Sentiment